‘Massachusetts remains in a position of strength to receive continued, meaningful investment’ 07-Feb-2023 By Rachel Arthur Around 25% of US venture capital biopharma investments flowed to Massachusetts in 2022: cementing the state’s position as a leader in the industry. But how will economic uncertainty affect the hub’s fortunes moving forward?
The growth of the UK’s ‘golden triangle’ 22-Jul-2020 By Ben Hargreaves Research outlines the pace of growth in the UK’s biohub and how it will progress towards 2050.